oncology

News in Brief: Copy number variant risk score better for predicting OS in ovarian cancer; Systemic therapy can be deferred in metastatic renal cell carcinoma; Tamoxifen contraception advice extended by TGA

Copy number variant risk score better for predicting OS in ovarian cancer A risk score based on copy number variants (CNV) for predicting overall survival in patients with ovarian cancer has been shown to be stronger than current ovarian cancer genomic biomarkers and available clinical features. The genetic association study of 564 patients with serous ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic